Sec Form 13D Filing - Lux Venture Partners IV LLC filing for Aeva Technologies Inc. (AEVA) - 2021-03-19

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No.     )*

AEVA TECHNOLOGIES, INC.

(Name of Issuer)

Class A Common Stock, $0.0001 par value per share

(Title of Class of Securities)

00835Q 103

(CUSIP Number)

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

March 12, 2021

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §240.13d-1(e), §240.13d-1(f) or §240.13d-1(g), check the following box.  ☐

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934, as amended (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 00835Q 103

This report shall not be deemed an admission that LVPIV is the beneficial owner of such securities for purposes of Section 13(d) or 13(g) of the Act and LVPIV disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

CUSIP No. 00835Q 103

This report shall not be deemed an admission that LVIV is the beneficial owner of such securities for purposes of Section 13(d) or 13(g) of the Act and LVIV disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

CUSIP No. 00835Q 103

This report shall not be deemed an admission that LCIP is the beneficial owner of such securities for purposes of Section 13(d) or 13(g) of the Act and LCIP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

CUSIP No. 00835Q 103

This report shall not be deemed an admission that LCIOP is the beneficial owner of such securities for purposes of Section 13(d) or 13(g) of the Act and LCIOP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

CUSIP No. 00835Q 103

This report shall not be deemed an admission that Mr. Hebert is the beneficial owner of such securities for purposes of Section 13(d) or 13(g) of the Act and he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

CUSIP No. 00835Q 103

This report shall not be deemed an admission that Mr. Wolfe is the beneficial owner of such securi ties for purposes of Section 13(d) or 13(g) of the Act and he disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

This Schedule 13D (this “Schedule 13D”) relates to the Class A common stock, $0.0001 par value per share (the “Common Stock”), of Aeva Technologies, Inc., a Delaware corporation (the “Issuer”). The principal executive offices of the Issuer are located at 555 Ellis Street, Mountain View, California 94043.

This Schedule 13D is being jointly filed by (i) Lux Ventures IV, L.P. (“LVIV”), (ii) Lux Venture Partners IV, LLC (“LVPIV”), (iii) Lux Co-Invest Opportunities, L.P. (“LCIOP”), (iv) Lux Co-Invest Partners, LLC (“LCIP”), (v) Peter Hebert and (vi) Josh Wolfe. Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” LVPIV is the general partner of LVIV and exercises voting and dispositive power over the shares of Common Stock held by LVIV. LCIP is the general partner of LCIOP and exercises voting and dispositive power over the shares of Common Stock held by LCIOP. This Schedule 13D relates to the shares of Common Stock directly owned by LVIV and LCIOP (the “LV Funds”). As a result of the foregoing, as of the date of this Schedule 13D, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, LVPIV may be deemed to beneficially own approximately 13.9% of the shares of the Issuer’s Common Stock outstanding as of March 12, 2021, LCIP may be deemed to beneficially own approximately 0.9% of the shares of the Issuer’s Common Stock outstanding as of March 12, 2021, and Messrs. Hebert and Wolfe may be deemed to beneficially own approximately 14.9% of the shares of the Issuer’s Common Stock outstanding as of March 12, 2021, as reported in the Issuer’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on March 18, 2021.

The principal business address of the Reporting Persons is c/o Lux Capital Management, LLC, 920 Broadway, 11th Floor, New York, NY 10010.

The principal business of the Reporting Persons is investments and/or investment management.

The Reporting Persons, nor, to the best knowledge of the foregoing, any of their controlling persons, have not been, during the last five years, convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

The Reporting Persons, nor, to the best knowledge of the foregoing, any of their controlling persons, have not been, during the last five years, party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

LVIV is a limited partnership organized under the laws of the State of Delaware. LVPIV is a limited liability company organized under the laws of the State of Delaware. LCIOP is a limited partnership organized under the laws of the State of Delaware. LCIP is a limited liability company organized under the laws of the State of Delaware. Each of Messrs. Hebert and Wolfe are United States citizens.

Funds for the purchase of the shares of Common Stock reported herein were derived from the capital contributions by the partners of the LV Funds and the available funds of such entities. A total of approximately $15,302,896 was paid to acquire the shares of common stock and preferred stock of Legacy Aeva (as defined below), which were subsequently converted into the shares of Common Stock of the Issuer reported herein upon closing of the Merger (as defined below). A total of $5,000,000 was paid to acquire the shares of Common Stock of the Issuer reported herein upon closing of the PIPE (as defined below).

The Reporting Persons acquired the securities reported herein for investment in the ordinary course of business by the LV Funds. The Reporting Persons reserve the right to acquire, or cause to be acquired, additional securities of the Issuer, to dispose of, or cause to be disposed of, such securities at any time or to formulate other purposes, plans or proposals regarding the Issuer or any of its securities, to the extent deemed advisable in light of general investment and trading policies of the Reporting Persons, market conditions or other factors.

Except as set forth herein, the Reporting Persons do not have any plan or proposal that would relate to, or result in, any of the matters set forth under subsections (a) through (j) of Item 4 of Schedule 13D.

The information in Item 6 is incorporated by reference herein.

The aggregate percentage of Common Stock reported in this Item 5 and set forth in Row 13 of the cover pages filed herewith is calculated based upon 211,042,833 shares of Common Stock outstanding as of March 12, 2021, as reported in the Issuer’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on March 18, 2021.

On March 12, 2021, the Issuer completed its reverse merger with Interprivate Acquisition Corp. (“Interprivate”) in accordance with the terms of the Business Combination dated as of November 2, 2021, by and among Interprivate, WLLY Merger Sub Corp. (“Merger Sub”) and Aeva, Inc., now known as Aeva Technologies, Inc. (“Legacy Aeva”), pursuant to which, among other matters, Merger Sub was merged with and into Legacy Aeva, with Legacy Aeva surviving the merger as a wholly owned subsidiary of the Issuer (the “Merger”).

Prior to the Merger, as a result of a series of private transactions with the Issuer, the LV Funds held an aggregate of 38,427 shares of common stock and an aggregate of 3,359,766 shares of preferred stock of Legacy Aeva. In connection with the Merger, each share of Legacy Aeva common stock and preferred stock held by the Lux Funds was converted into an aggregate of 30,844,005 shares of Common Stock of the Issuer.

Concurrently with the closing of the Merger, LCIOP purchased 500,000 shares of Common Stock of the Issuer in a private placement (the “PIPE”).

As a result of the Merger and the PIPE, the LV Funds, collectively, and Messrs. Hebert and Wolfe, as the managing members of the LV Funds, may be deemed to beneficially own 31,344,005 shares of Common Stock, representing approximately 14.9% of the Issuer’s issued and outstanding shares of Common Stock deemed outstanding as of March 12, 2021. Based on the Issuer’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 18, 2021 there were 211,042,833 shares of Common Stock issued and outstanding as of March 12, 2021.

Except as set forth in this Schedule 13D, the Reporting Persons have not effected any transaction in the Common Stock, or securities convertible into, exercisable for or exchangeable for, shares of Common Stock in the last 60 days.

On March 12, 2021, each of the LV Funds entered into that certain Amended and Restated Registration Rights Agreement (the “Registration Rights and Lock-Up Agreement”), pursuant to which, among other things, each has agreed not to, except in limited circumstances, offer, pledge, sell, contract to sell, transfer or dispose of, directly or indirectly, or engage in swap or similar transactions with respect to, any shares of Common Stock received in the Merger during the period commencing on March 12, 2021 and continuing until the date that is 180 days from March 12, 2021. In addition, pursuant to the Registration Rights and Lock-Up Agreement, the LV Funds have certain registration rights with respect to the shares of Common Stock received in the Merger. The foregoing description of the Registration Rights and Lock-Up Agreement is qualified in its entirety by reference to the full text of the Registration Rights and Lock-Up Agreement, a copy of which is filed as Exhibit 99.4 hereto, and incorporated herein by reference.

Pursuant to a Stockholders Agreement, dated March 12, 2021, between the Issuer and certain stockholders party thereto, the LV Funds have the right to designate a director to the Issuer’s board of directors. Shahin Farshchi, who currently serves as a venture partner at LVIV, currently serves as such designee. The foregoing description of the Stockholders Agreement is qualified in its entirety by reference to the full text of the Stockholders Agreement, a copy of which is filed as Exhibit 99.5 hereto, and incorporated herein by reference.

Pursuant to the subscription agreement for the PIPE, the LV Funds have certain registration rights with respect to the shares of Common Stock acquired in the PIPE.

Other than the transactions described in this Item 6 and elsewhere throughout this Schedule 13D, there are no contracts, arrangements, understandings or relationships between the Reporting Persons and any other person, with respect to the Common Stock of the Issuer.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: March 19, 2021